Vincenzo Mazzaferro, MD is currently the Director of the Gastrointestinal and Hepato-Pancreatic Surgery and Liver Transplantation Unit of the Istituto Nazionale dei Tumori of Milan and the Vice-Scientific Director for clinical research in the same center. Prof. Mazzaferro has completed milestone studies for the clinical management of HCC, especially in the setting of liver transplantation.

Expanding eligibility criteria for liver transplantation for hepatocarcinoma on cirrhosis in relation to the efficacy of the retrospective (downstaging) of the neoplasm: prospective randomized validation study (Studio XXL)", funded by the Ministry of Health. Genomic Predictors and Oncogenic Drivers in Hepatocellular Carcinoma (HEPTROMIC)", funded by the European Commission. ROL - Early liver and biliary tumors", funded by the Lombardy Region. Study of inflammatory profiles associated with IL-6 as predictors of recurrence in patients with liver cancer", funded by the Ministry of Health. Using HBsAg positive, positive anti-HBcore, or positive anti-HCV donors using national guidelines: Improving the liver allocation pattern through the collection and evaluation of organ and patient survival results in the short, medium and long term, "funded by the Ministry of Health.